Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Doxorubicin Induced Cardiomyopathy”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Not applicableStudy completedNCT03505164
What this trial is testing

The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor

Who this might be right for
Doxorubicin Adverse ReactionCardiomyopathies, SecondaryBreast Cancer
Rush University Medical Center 42
Not applicableStudy completedNCT03000036
What this trial is testing

Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients

Who this might be right for
Breast Cancer FemaleDoxorubicin Induced Cardiomyopathy
University of Campinas, Brazil 27
Testing effectiveness (Phase 2)Ended earlyNCT02677714
What this trial is testing

99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Advanced Accelerator Applications 14
Testing effectiveness (Phase 2)Looking for participantsNCT06427226
What this trial is testing

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

Who this might be right for
Doxorubicin Induced CardiomyopathyBreast Cancer
Tanta University 46
Not applicableUnknownNCT05584163
What this trial is testing

Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves

Who this might be right for
Breast Cancer
Ewha Womans University Mokdong Hospital 72
Large-scale testing (Phase 3)UnknownNCT05792293
What this trial is testing

Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity

Who this might be right for
Doxorubicin Induced Cardiomyopathy
Ain Shams University 100
Not applicableStudy completedNCT05731375
What this trial is testing

Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage

Who this might be right for
Doxorubicin Induced CardiomyopathyChemotherapeutic ToxicityAnthracyclines
UMC Utrecht 12
Early research (Phase 1)Study completedNCT04023110
What this trial is testing

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Who this might be right for
CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more
Abramson Cancer Center at Penn Medicine 68
Not applicableUnknownNCT04461223
What this trial is testing

Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR

Who this might be right for
CardiotoxicityOsteosarcomaMyocardial Injury+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 55
Large-scale testing (Phase 3)UnknownNCT06103279
What this trial is testing

Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin

Who this might be right for
Cancer
Ain Shams University 40
Not applicableUnknownNCT04852965
What this trial is testing

Late Anthracycline Induced Cardiotoxicity- Childhood Cancer Survivors

Who this might be right for
Anthracycline Induced Cardiotoxicity
Queen's University, Belfast 103
Testing effectiveness (Phase 2)UnknownNCT06092606
What this trial is testing

Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

Who this might be right for
CancerHeart FailureArrhythmia+2 more
Monyan Pharmaceutical (Shanghai) Co., Ltd. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370506
What this trial is testing

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Tanta University 36
Not applicableStudy completedNCT02796365
What this trial is testing

Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy

Who this might be right for
Doxorubicin Induced CardiomyopathyBreast CancerGastric Cancer+1 more
Henry Ford Health System 29